LAVA Therapeutics N.V. (LVTX)

LAVA Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	39.67	35.02	44.23	100.33	90.87	15.82
Short-Term Investments	26.88	41.56	51.34	32.54	42.33	-
Cash & Short-Term Investments	66.56	76.58	95.57	132.87	133.2	15.82
Cash Growth	-29.62%	-19.88%	-28.07%	-0.25%	742.10%	115.56%
Accounts Receivable	-	-	-	3.25	0.36	1.14
Other Receivables	-	-	-	-	0.37	0.34
Receivables	-	-	-	3.25	0.73	1.48
Prepaid Expenses	1.56	1.07	1.63	4.41	2.57	0.12
Other Current Assets	1.66	1.65	1.7	-	-	0.81
Total Current Assets	69.78	79.3	98.9	140.53	136.51	18.22
Property, Plant & Equipment	1.28	1.44	2.46	2.08	1.95	1.5
Other Long-Term Assets	0.1	0.09	0.32	0.81	0.8	0.77
Total Assets	71.16	80.83	101.67	143.43	139.25	20.49
Accounts Payable	1.52	2.72	4.45	3.97	2.55	0.93
Accrued Expenses	6.88	9.13	4.29	7.83	1.57	1.27
Current Portion of Long-Term Debt	-	4.89	5.28	4.64	-	-
Current Portion of Leases	0.31	0.32	0.42	0.38	0.26	0.21
Current Unearned Revenue	-	-	-	-	1.53	4.52
Other Current Liabilities	1.1	0.95	0.46	5.14	5.34	0.41
Total Current Liabilities	10.37	18.01	14.89	21.95	11.25	7.34
Long-Term Debt	-	-	-	-	4.28	3.6
Long-Term Leases	0.01	0.08	0.42	0.43	0.32	0.27
Long-Term Unearned Revenue	35	35	35	35	-	1.66
Other Long-Term Liabilities	-	-	-	-	5.03	-
Total Liabilities	45.37	53.09	50.31	57.39	20.88	12.87
Common Stock	3.72	3.72	3.72	3.72	3.65	-
Additional Paid-In Capital	212.2	211.66	208.41	194.42	192.27	41.09
Retained Earnings	-178.45	-174.97	-149.86	-108.07	-76.16	-33.39
Comprehensive Income & Other	-11.68	-12.66	-10.9	-4.03	-1.39	-0.08
Shareholders' Equity	25.78	27.75	51.36	86.04	118.37	7.62
Total Liabilities & Equity	71.16	80.83	101.67	143.43	139.25	20.49
Total Debt	0.31	5.28	6.11	5.45	4.87	4.08
Net Cash (Debt)	66.25	71.3	89.46	127.42	128.34	11.74
Net Cash Growth	-25.10%	-20.30%	-29.79%	-0.72%	993.54%	110.59%
Net Cash Per Share	2.47	2.66	3.35	4.92	6.50	29.40
Filing Date Shares Outstanding	26.31	26.31	26.29	26.29	25.78	0.4
Total Common Shares Outstanding	26.31	26.31	26.29	26.29	25.78	0.4
Working Capital	59.41	61.29	84	118.58	125.26	10.89
Book Value Per Share	0.98	1.05	1.95	3.27	4.59	19.09
Tangible Book Value	25.78	27.75	51.36	86.04	118.37	7.62
Tangible Book Value Per Share	0.98	1.05	1.95	3.27	4.59	19.09
Buildings	-	-	-	0.12	0.12	0.11
Machinery	-	2.65	2.96	2.42	1.95	1.34
Leasehold Improvements	-	0.36	0.38	-	-	-

Updated May 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q